Together, SPP1+ macrophages and POSTN+ CAFs form physical and biochemical tumor immune barriers (TIBs) that shield tumor cores from T-cell access and reduce the efficacy of immune checkpoint blockade (ICB) therapies [147]. The gene discussed is POSTN; the disease is neoplasm.